Urinary lithiasis and indinavir sulfate in HIV-infected patients: 4 cases.

被引：0
|
作者：
Chefchaouni, MC [1 ]
Thiounn, N [1 ]
Flam, T [1 ]
Zerbib, M [1 ]
Debre, B [1 ]
机构：
[1] Hop Cochin, Urol Clin, F-75679 Paris 14, France
来源：
JOURNAL D UROLOGIE | 1997年 / 103卷 / 1-2期
关键词：
urinary stones; iatrogenic; AIDS; VIH;
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
We report on 4 cases of urinary stone observed in patients treated with the drug Crixivan(R) (Indinavir Sulfate) and review the literature. Comments include stone composition, clinical aspects, treatment and prevention.
引用
收藏
页码：35 / 36
页数：2
相关论文
共 50 条
  • [41] Unexpected atazanavir-associated biliary lithiasis in an HIV-infected patient
    Courbon, Eve
    Laylavoix, Francois
    Soulie, Cathia
    Le Beller, Christine
    Calvez, Vincent
    Katlama, Christine
    Peytavin, Gilles
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (01) : 250 - 251
  • [42] Indinavir: A rare urinary stone in HIV-1-infected patients - Occurrence and crystal properties
    Tessadri, R
    Griesser, UJ
    Prillinger, M
    Wurst, K
    EUROPEAN POWDER DIFFRACTION EPDIC 8, 2004, 443-4 : 407 - 410
  • [43] Increasing adverse events with indinavir dosages and plasma concentrations in four different ritonavir-indinavir containing regimen in HIV-infected patients
    Lamotte, C.
    Peytavin, G.
    Perre, P.
    Chavanet, P.
    De Truchis, P.
    Gilquin, J.
    Winter, C.
    Katlama, C.
    Farinotti, R.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2001, 15 : 67 - 67
  • [44] Disseminated Cryptococcal Infection in HIV-Infected Patients: A Retrospective Clinicopathological Review of 4 Autopsy Cases
    Khaba, Moshawa Calvin
    Kgole, Mamokoma Becky
    Nevondo, Lesedi Makgwethele
    Van Aswegen, Willem Johannes
    Mabelane, Tshegofatso
    Makhado, Ndivhuho Agnes
    CLINICAL PATHOLOGY, 2022, 15
  • [45] Clinical outcome among HIV-infected patients starting saquinavir hard gel compared to ritonavir or indinavir
    Kirk, O
    Mocroft, A
    Pradier, C
    Bruun, JN
    Hemmer, R
    Clotet, B
    Miller, V
    Viard, JP
    Phillips, AN
    Lundgren, JD
    AIDS, 2001, 15 (08) : 999 - 1008
  • [46] Interoccasion variability of indinavir in HIV infected patients.
    Gatti, G
    Di Biagio, A
    De Pascalis, RC
    Bassetti, M
    Vella, S
    Bassetti, D
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (02) : 156 - 156
  • [47] Low-doses of indinavir boosted with ritonavir in HIV-infected Thai patients: pharmacokinetics, efficacy and tolerability
    Cressey, TR
    Leenasirimakul, P
    Jourdain, G
    Tod, M
    Sukrakanchana, P
    Kunkeaw, S
    Puttimit, C
    Lallemant, M
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 55 (06) : 1041 - 1044
  • [48] Lamivudine and indinavir/ritonavir maintenance therapy in highly pretreated HIV-infected patients (Vista ANRS 109)
    Launay, Odile
    Duval, Xavier
    Dalban, Cecile
    Descamps, Diane
    Peytavin, Gilles
    Certain, Agnes
    Mouajjah, Said
    Ralaimazava, Pascal
    Verdon, Renaud
    Costagliola, Dominique
    Clavel, Francois
    ANTIVIRAL THERAPY, 2006, 11 (07) : 889 - 899
  • [49] Pharmacokinetic interaction between rifampin and the combination of indinavir and low-dose ritonavir in HIV-infected patients
    Justesen, US
    Andersen, ÅB
    Klitgaard, NA
    Brosen, K
    Gerstoft, J
    Pedersen, C
    CLINICAL INFECTIOUS DISEASES, 2004, 38 (03) : 426 - 429
  • [50] Atazanavir urinary stones in an HIV-infected patient
    Pacanowski, Jerome
    Poirier, Jean-Marie
    Petit, Isabelle
    Meynard, Jean-Luc
    Girard, Pierre-Marie
    AIDS, 2006, 20 (16) : 2131 - 2131
12345